Page 12 - Edge Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NeonMind Biosciences Inc: NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity NeonMind Biosciences Inc. ( FSE: 6UF) (" NeonMind") is pleased to announce that on March 4, 2020 NeonMind engaged Philippe Martin as a drug development consultant. Figure 1: NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity To view an enhanced version of Figure 1, please visit: https://orders.newsfilecorp.com/files/7646/76539_neonmi2.jpg Mr. Martin has 20 years of biotechnology and pharmaceutical industry exper...

VANCOUVER, British Columbia, Feb. 22, 2021 (GLOBE NEWSWIRE) — Victory Square Technologies Inc. (“ Victory Square”) (CSE:VST) (OTC:VSQTF) (FWB:6F6) is pleased to announce that further to its news release dated February 22, 2021, its portfolio company GameOn Entertainment Technologies Inc. (“ GameOn”) has increased the size of its previously announced non-brokered private placement (the “ SR Offering”) of subscription receipts of GameOn (“ Subscription Receipts”) from $1.5 million to $3 million due to strong investor demand. Each Subscription Receipt will be sold at a price of...

Share: The near unanimous vote demonstrated the strong level of support from all parties for single-event sports wagering in Canada. GameOn provides legalized sportsbooks with gaming software solutions, including patent-pending first-screen technology that lets fans make bets with remote controls. GameOn recently announced advisors with deep sports betting experience: J Moses, a respected game industry veteran who also served as an advisor for the sports wagering platform Bet.Works (recently acquired by Ballys), Mike Vorhaus, seed investor at DraftKings and Skillz, Sean Hurley, previously ser...

NeonMind Biosciences Inc: NeonMind Appoints Dr. Frank Russo to Lead Development of Music-Based Program for Psilocybin Clinical Trials NeonMind Biosciences Inc. ( CSE: NEON) (" NeonMind") a company conducting research into the potentially therapeutic uses of compounds found in psychedelic mushrooms, is pleased to announce that it has added Frank Russo as an advisor and consultant to assist the Company in selecting or developing music playlists for its clinical trials or for use with treatments to support optimum mental health. NeonMind Engages Music Expert Dr. Frank Russo To view an enhanced ...

NeonMind Biosciences Inc: NeonMind Engages Dr. C. Laird Birmingham to Develop Protocols for Phase 2 Clinical Trial Using Psilocybin to Treat Obesity NeonMind Biosciences Inc. (CSE: NEON) (" NeonMind"), a psychedelic drug development company, is pleased to announce that it has engaged Dr. C. Laird Birmingham to consult with NeonMind to develop protocols for its Phase 2 Clinical Trial administering psilocybin to treat obese patients. Dr. Birmingham is a Specialist in Internal Medicine, an Epidemiologist and Biostatistician, and a Professor of Psychiatry at the University of British Columbia whe...